A041701: A Randomized Phase II/III Study of Conventional Chemotherapy +/- Uproleselan (GMI – 1271) in Older Adults with Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy

A041702: A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (> 70 Years of Age) with Chronic Lymphocytic Leukemia (CLL)

Dana Farber 14-174: Study of Precursor Hematological Malignancies to Assess the Relationship Between Molecular Events of Progression and Clinical Outcome

E1910: A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia in Adults

S1318: Ph II – Blinatumomab and POMP (Prednisone, Vincristine, Methotrexate, 6-Mercaptopurine) for Pts >/= 65 Yrs w/ Newly Diagnosed Ph- ALL and of Dasatinib, Prednisone and Blinatumomab for Patients >/= 65 Yrs w/ Newly Diagnosed Ph+ ALL